-+ 0.00%
-+ 0.00%
-+ 0.00%

Evotec Secures $2.5M Grant To Generate Critical Data Supporting New TB Regimens

Benzinga·05/07/2025 07:13:27
Listen to the news
  • Gates Foundation supports Evotec with a $ 2.5 M grant to generate critical data supporting development of next generation tuberculosis drug combinations.
  • The collaboration continues a successful partnership on evaluating new treatment regimens aimed at reducing treatment duration and overcoming resistance to current therapies.